Viral hepatitis

AB1_VIRAL_HEPATITIS

animal viral hepatitis: A hepatitis that involves viral infection of an animal causing inflammation of the liver.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B15-B19 Hospital discharge: ICD-9 — 070 Hospital discharge: ICD-8 — 070 Cause of death: ICD-10 — B15-B19 Cause of death: ICD-9 — 070 Cause of death: ICD-8 — 070 2 out of 7 registries used, show all original rules.	3043
4. Check minimum number of events None	3043
5. Include endpoints AB1_HEPATITIS_A AB1_HEPATITIS_B AB1_HEPATITIS_OTHER_VIRAL	3043
6. Filter based on genotype QC (FinnGen only)	3043

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	AB1_VIRAL_HEPATITIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	AB1_HEPATITIS_A\|AB1_HEPATITIS_B\|AB1_HEPATITIS_OTHER_VIRAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B1[5-9]
HD_ICD_9	070
HD_ICD_8	070
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B1[5-9]
COD_ICD_9	070
COD_ICD_8	070
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral hepatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31514	12176	18725
Only index persons	28006	11243	16763
Unadjusted period prevalence (%)
Whole population	0.46	0.35	0.52
Only index persons	0.55	0.41	0.64
Median age at first event (years)
Whole population	32.94	31.00	34.14
Only index persons	32.37	30.40	33.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3043	1401	1642
Unadjusted period prevalence (%)	0.61	0.48	0.72
Median age at first event (years)	34.69	32.82	36.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2768: Matched controls
27680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7040.9

323.0

1823

P19

ICPC

Drug abuse

70.0

323.0

467

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

195.1

323.0

443

N05BA01

ATC

diazepam; systemic, rectal

8.1

323.0

957

1697

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

195.7

323.0

373

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

114.5

323.0

410

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

22.6

323.0

1279

1012

N05AH04

ATC

quetiapine; oral

5.9

321.0

1122

2886

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

93.8

319.5

352

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

152.2

308.2

323

T36

ICD-10 Finland

Poisoning by systemic antibiotics

11.3

307.1

621

690

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

48.2

298.4

365

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

81.8

290.7

326

Z72.2

ICD-10 Finland

Drug use

82.5

287.4

322

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

11.7

264.6

522

541

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.9

262.7

664

1061

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

129.8

243.0

259

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

853.7

242.5

235

N05AH03

ATC

olanzapine; systemic

7.7

239.7

615

993

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

108.4

235.8

256

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

142.6

233.7

247

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

277.2

226.9

229

N05CD07

ATC

temazepam; oral

6.8

218.0

610

1103

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

216.5

205

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

118.8

212.8

229

N03AE01

ATC

clonazepam; systemic

8.9

211.5

485

646

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

106.4

206.7

225

N05BA04

ATC

oxazepam; oral

4.0

204.2

1072

3807

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.6

202.2

471

641

N07BB01

ATC

disulfiram; oral

7.6

193.1

489

756

N06AX11

ATC

mirtazapine; oral

3.5

191.9

1278

5452

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

2005.9

185.4

178

N05AA02

ATC

levomepromazine; systemic

9.3

184.2

408

506

N05BA12

ATC

alprazolam; oral

5.4

178.9

602

1344

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.6

175.9

577

1248

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.8

170.0

535

1097

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

64.2

169.3

197

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

50.9

164.5

199

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

60.6

163.5

192

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.4

159.9

314

308

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

147.0

157.2

166

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

12.9

148.3

273

233

Z2446

NOMESCO Finland

Social worker

5.9

142.0

434

845

P18

ICPC

Medication abuse

35.7

141.4

184

N06AB04

ATC

citalopram; systemic

3.3

139.6

876

3381

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

90.6

138.7

154

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.8

136.2

676

2158

F60.2

ICD-10 Finland

Dissocial personality disorder

56.9

135.7

161

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.3

134.6

264

256

SPAT1272

SPAT

Drug screening

63.5

133.9

156

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

9.0

133.6

298

366

P15

ICPC

Chronic alcohol abuse

8.8

133.5

302

380

N05CF01

ATC

zopiclone; oral

3.0

130.7

1031

4624

N05AX08

ATC

risperidone; systemic

5.1

127.3

441

987

C07AA05

ATC

propranolol; systemic

3.2

127.0

816

3164

A46

ICD-10 Finland

Erysipelas

4.1

125.6

554

1581

EBA00

NOMESCO Finland

Extraction of tooth

2.7

125.2

1224

6233

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

100.6

122.2

134

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

22.1

121.2

180

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

216.2

120.7

124

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

43.7

119.7

149

N05BA02

ATC

chlordiazepoxide; systemic

11.2

119.3

234

226

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.7

119.0

228

210

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

183.8

118.4

123

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

17.9

116.1

185

110

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.9

113.9

533

1591

T74.1

ICD-10 Finland

Physical abuse

10.4

113.8

232

241

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

175.9

113.2

118

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

87.3

112.1

125

D72

ICPC

Viral hepatitis

293.0

110.8

112

N05AF03

ATC

chlorprothixene; systemic

8.2

110.1

258

341

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

371.4

108.1

108

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

40.8

107.8

136

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

30.3

106.5

144

SPAT1265

SPAT

Breathalyser

15.8

106.4

178

120

0709X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma

+∞

103.8

F10.24

ICD-10 Finland

Alcohol depence active use

11.7

101.9

195

178

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

52.6

100.8

121

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

155.8

99.8

105

N06AB06

ATC

sertraline; oral

3.5

99.2

539

1802

N03AG01

ATC

valproic acid; systemic, rectal

4.6

98.8

375

911

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

101.2

97.7

107

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

335.3

97.6

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.7

97.5

885

4163

B15.9

ICD-10 Finland

Hepatitis A without hepatic coma

+∞

97.5

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

8.3

97.1

225

291

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

+∞

96.4

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

7.0

95.3

248

382

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

12.2

95.1

178

155

Z3231

NOMESCO Finland

Registered nurse

2.6

94.6

909

4401

N05AD01

ATC

haloperidol; systemic

8.4

91.8

211

269

F10.09

ICD-10 Finland

Alcohol intoxication UNS

8.5

91.6

209

263

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.2

90.6

303

640

N06AX16

ATC

venlafaxine; oral

3.0

90.5

614

2393

N06AB03

ATC

fluoxetine; oral

3.3

89.9

510

1749

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

10.3

89.2

182

188

N05BE01

ATC

buspirone; oral

7.2

88.9

226

336

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

19.9

88.3

135

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

188.1

87.8

AA1AD

NOMESCO Finland

CT of head and brain

2.8

87.0

681

2900

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.5

86.5

215

309

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

86.3

1153

6552

N03AX16

ATC

pregabalin; oral

2.6

86.1

758

3457

07009

ICD-8 Finland

Infectious hepatitis, Unspecified

+∞

85.9

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

88.5

84.6

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

19.8

84.3

129

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

84.2

530

1952

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

832.6

82.9

F60.9

ICD-10 Finland

Personality disorder, unspecified

10.6

82.7

166

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.3

82.6

468

1596

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

8.8

81.8

182

219

WX110

NOMESCO Finland

Local anesthesy

2.3

81.8

2088

15796

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.2

81.7

484

1704

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

81.3

483

1704

N05AH02

ATC

clozapine; systemic

6.7

80.5

215

342

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

22.6

79.8

117

07004

ICD-8 Finland

Infectious hepatitis, Alia

+∞

79.6

Z2221

NOMESCO Finland

Medical doctor

2.4

78.4

897

4667

EBA30

NOMESCO Finland

Excision of root of tooth

4.9

77.8

273

605

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

77.7

353

1004

N02AX02

ATC

tramadol; systemic, rectal

2.2

75.6

1188

7143

P16

ICPC

Acute alcohol abuse

8.9

75.4

166

196

N06AA12

ATC

doxepin; systemic

5.3

75.3

243

490

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

12.2

75.3

140

120

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

13.4

75.1

134

105

N05AX12

ATC

aripiprazole; systemic

4.5

75.0

289

704

N06AB05

ATC

paroxetine; oral

4.0

73.7

320

872

F61.0

ICD-10 Finland

Mixed personality disorders

8.0

73.2

172

226

N06AB10

ATC

escitalopram; oral

2.4

72.9

769

3815

SPAT1227

SPAT

Substance abuse rehabilitation

15.3

72.5

122

N05CF02

ATC

zolpidem; oral

2.6

72.5

613

2694

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.7

71.2

338

995

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

8.1

70.9

166

217

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.4

70.7

714

3452

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.0

70.7

1515

10274

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

7.5

70.6

174

246

A06AD11

ATC

lactulose; oral

3.3

69.6

384

1271

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.9

69.4

165

221

ZY000

NOMESCO Finland

Hospital inpatient

9.5

69.0

146

161

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

67.6

68.7

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

+∞

68.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

67.5

1256

7986

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.7

67.2

150

181

Z3226

NOMESCO Finland

Physiotherapist

2.6

67.0

573

2519

-1

NOMESCO Finland

2.1

66.3

1137

6975

R4110

NOMESCO Finland

Physiotherapy

2.3

66.0

764

3934

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

10.4

66.0

133

134

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

11.2

65.7

127

118

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

56.5

65.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

64.9

753

3876

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

+∞

64.8

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

64.7

669

3250

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

64.5

512

2150

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

64.2

629

2972

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

64.1

371

1269

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

324.3

63.7

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

81.0

63.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

63.2

593

2736

N05AB01

ATC

dixyrazine; systemic

11.8

62.6

118

104

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

62.4

1041

6271

SPAT1254

SPAT

Administration of medicine

2.9

62.4

424

1617

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

47.4

60.8

ZY010

NOMESCO Finland

Hospital outpatient

4.0

60.3

262

710

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

46.8

59.8

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.9

59.4

1646

11957

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

158.5

59.1

S06.0

ICD-10 Finland

Concussion

2.9

58.9

393

1476

N03AX12

ATC

gabapentin; oral

2.6

58.9

489

2101

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

63.3

58.6

K02.1

ICD-10 Finland

Caries of dentine

1.9

58.2

1788

13437

WX290

NOMESCO Finland

Other blockade of nerve

1.9

58.1

1495

10530

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

92.1

57.1

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

5.2

56.9

187

383

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

569.4

56.8

J01FF01

ATC

clindamycin; systemic

2.1

56.8

823

4633

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.7

56.7

266

769

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

66.5

56.5

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

9.9

56.2

116

122

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

150.6

56.1

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

122.6

56.0

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.9

56.0

387

1483

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.3

55.8

119

133

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.2

55.7

181

366

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.2

55.6

182

371

S01.0

ICD-10 Finland

Open wound of scalp

3.4

55.4

293

932

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

55.3

311

1036

EBA15

NOMESCO Finland

Extraction of large number of teeth

5.4

55.3

174

339

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.7

54.7

165

306

N05AB03

ATC

perphenazine; systemic, rectal

4.5

53.3

199

466

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.6

53.0

262

790

WX892

NOMESCO Finland

Monitored bed care

3.6

52.5

260

785

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

52.4

2065

16627

Y07

ICD-10 Finland

Other maltreatment

10.6

52.4

104

102

B18.9

ICD-10 Finland

Chronic viral hepatitis, unspecified

+∞

52.2

N05AA01

ATC

chlorpromazine; systemic, rectal

8.3

52.2

119

149

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

12.6

52.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

51.9

659

3479

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

33.2

51.9

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

56.6

51.7

P29

ICPC

Psychological sympt/compl other

3.3

51.5

280

908

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

51.4

500

2325

WYA30

SPAT

19.5

51.1

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.8

50.9

232

653

P01

ICPC

Feeling anxious/nervous/tense

2.6

50.8

419

1780

ZXD05

NOMESCO Finland

Urgent procedure

2.0

50.4

915

5579

K05.31

ICD-10 Finland

Periodontitis pronounced

3.1

50.2

309

1091

N04AA02

ATC

biperiden; systemic

6.8

50.1

130

198

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

59.2

49.6

N03AX09

ATC

lamotrigine; oral

3.4

49.1

252

781

0703A

ICD-9 Finland

Viral hepatitis B without mention of hepatic coma

+∞

49.1

K04.0

ICD-10 Finland

Pulpitis

2.5

48.8

417

1803

N05CD08

ATC

midazolam; nasal, systemic

8.8

48.7

107

126

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.4

48.6

184

437

K04.7

ICD-10 Finland

Periapical abscess without sinus

3.5

48.5

244

745

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

70.0

48.2

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

15.9

48.1

R50.9

ICD-10 Finland

Fever, unspecified

2.4

48.0

444

2003

TKC20

NOMESCO Finland

Catheterisation of bladder

3.8

48.0

218

612

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

475.7

47.5

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

15.3

47.3

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

7.3

47.3

117

166

K08.3

ICD-10 Finland

Retained dental root

3.3

47.1

256

829

0701A

ICD-9 Finland

Viral hepatitis A without mention of hepatic coma

+∞

47.0

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

5.1

46.9

154

315

N06BA04

ATC

methylphenidate; oral

4.9

46.8

161

346

N05AD03

ATC

melperone; systemic

11.2

46.8

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.5

46.4

231

699

K02.9

ICD-10 Finland

Dental caries, unspecified

7.5

46.3

112

154

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

10.4

45.7

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.7

45.6

340

1357

N05AF05

ATC

zuclopenthixol; systemic

9.3

45.6

108

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

9.6

45.1

101

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.5

44.8

226

691

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

58.8

44.5

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

8.9

44.2

111

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.1

44.2

124

210

A41.9

ICD-10 Finland

Sepsis, unspecified

5.3

44.1

139

271

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

4.2

44.0

174

431

V03AA01

ATC

7.1

43.8

110

160

F51.0

ICD-10 Finland

Nonorganic insomnia

2.3

43.8

451

2139

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

43.4

277

1002

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

434.2

43.3

N05BA06

ATC

lorazepam; systemic, sublingual

3.9

43.1

190

519

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

16.8

43.0

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.1

42.6

252

865

Z72.1

ICD-10 Finland

Alcohol use

7.8

42.5

100

132

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.6

42.4

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.6

42.2

205

607

P72

ICPC

Schizophrenia

5.4

42.2

131

251

Z71.8

ICD-10 Finland

Other specified counselling

1.9

42.1

716

4202

T51.0

ICD-10 Finland

Toxic effect: Ethanol

11.9

42.0

P74

ICPC

Anxiety disorder/anxiety state

3.8

42.0

187

515

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

42.0

265

951

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

12.2

41.8

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

50.9

41.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

41.7

486

2439

WX002

NOMESCO Finland

Sedation and analgesia

2.2

41.7

486

2441

ZXE00

NOMESCO Finland

One hour or less

1.8

41.7

1044

7003

ZXD35

NOMESCO Finland

Usual procedure

4.5

41.5

152

349

IGV01

NOMESCO Finland

Psychiatric network contact

9.8

41.4

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.9

41.4

120

212

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.8

41.3

182

497

S10

ICPC

Boil/carbuncle

3.4

41.1

212

658

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

41.0

890

5691

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

145.5

40.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

40.8

329

1369

N05AN01

ATC

lithium; oral

4.7

40.6

144

320

D10

ICPC

Vomiting

2.9

40.5

266

979

F05.9

ICD-10 Finland

Delirium, unspecified

9.8

40.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

40.2

722

4312

X57

ICD-10 Finland

Unspecified privation

5.5

40.0

123

233

R05

ICPC

Cough

2.0

39.9

600

3348

X78

ICD-10 Finland

Intentional self-harm by sharp object

11.0

39.8

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

33.1

39.8

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.3

39.5

125

245

R74

ICPC

Upper respiratory infection acute

1.8

39.5

903

5857

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

39.4

899

5824

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

23.8

39.3

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

7.2

39.1

139

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

26.2

39.0

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

138.7

38.8

A02BC02

ATC

pantoprazole; systemic

1.7

38.7

1576

12140

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

38.6

P99

ICPC

Psychological disorders other

4.2

38.5

155

390

C03CA01

ATC

furosemide; systemic

2.2

38.4

462

2346

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

22.0

38.4

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

30.5

38.3

M79.6

ICD-10 Finland

Pain in limb

1.8

38.0

892

5816

N06AX21

ATC

duloxetine; oral

2.4

37.9

343

1517

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

85.3

37.9

KMAK

NOMESCO Finland

1.7

37.8

1564

12061

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

15.4

37.5

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

7.5

37.4

123

N06AX03

ATC

mianserin; oral

3.6

37.2

175

505

N07BC51

ATC

buprenorphine, combinations; sublingual

372.2

37.1

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.3

37.0

S18

ICPC

Laceration/cut

1.7

37.0

1004

6834

T40.2

ICD-10 Finland

Poisoning: Other opioids

83.3

36.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

36.2

705

4305

RS220

NOMESCO Finland

6.8

36.2

140

P01AB01

ATC

metronidazole; oral, rectal

1.7

36.0

997

6811

A03

ICPC

Fever

2.0

35.9

537

2978

IFC99

NOMESCO Finland

Other biological psychiatric intervention

31.8

35.7

A02BC01

ATC

omeprazole; systemic

1.9

35.4

656

3936

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

5.4

35.3

110

212

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.8

35.3

156

427

A01

ICPC

Pain general/multiple sites

2.9

35.2

235

872

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

13.2

35.1

D11

ICPC

Diarrhoea

2.2

34.9

384

1865

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

96.3

34.8

N06AA06

ATC

trimipramine; systemic

5.0

34.5

114

235

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

52.0

34.5

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

16.5

34.2

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

341.2

34.0

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

4.6

33.9

121

271

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.6

33.9

273

1132

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

13.0

33.9

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

3.7

33.9

154

432

L17

ICPC

Foot/toe symptom/complaint

1.9

33.8

603

3557

F20

ICD-10 Finland

Schizophrenia

9.0

33.6

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.9

33.6

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.6

33.5

119

265

F20.0

ICD-10 Finland

Paranoid schizophrenia

8.7

33.4

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.4

33.4

125

294

N06AX12

ATC

bupropion; oral

2.6

33.3

264

1084

L03.9

ICD-10 Finland

Cellulitis, unspecified

5.4

33.3

102

193

K92.0

ICD-10 Finland

Haematemesis

5.5

33.3

101

189

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.8

33.2

114

245

T40.1

ICD-10 Finland

Poisoning: Heroin

330.9

32.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

32.9

257

1045

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

32.9

352

1684

L12

ICPC

Hand/finger symptom/complaint

2.1

32.9

394

1987

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

22.7

32.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.9

32.6

216

796

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

16.5

32.4

B18.0

ICD-10 Finland

Chronic viral hepatitis B with delta-agent

+∞

32.3

K76.9

ICD-10 Finland

Liver disease, unspecified

8.2

32.3

Z01.2

ICD-10 Finland

Dental examination

1.6

32.0

1131

8202

ZXY60

NOMESCO Finland

2-person team, nurses

9.8

31.8

N03AF01

ATC

carbamazepine; oral, rectal

3.4

31.7

162

499

Y09

ICD-10 Finland

Assault by unspecified means

9.9

31.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

31.5

430

2287

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

31.3

904

6191

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.8

31.2

R11

ICD-10 Finland

Nausea and vomiting

2.7

31.2

227

886

K02.2

ICD-10 Finland

Caries of cementum

3.9

31.2

135

363

WX730

NOMESCO Finland

Conventional respirator

6.6

31.2

128

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

30.9

355

1754

F92.0

ICD-10 Finland

Depressive conduct disorder

15.9

30.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

30.6

181

620

F40.1

ICD-10 Finland

Social phobias

4.0

30.5

125

320

WX110

SPAT

3.1

30.1

174

587

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.7

29.9

117

F61

ICD-10 Finland

Mixed and other personality disorders

12.2

29.7

SPAT1240

SPAT

Therapeutic discussion

2.1

29.7

373

1913

N05CD02

ATC

nitrazepam; oral

7.2

29.7

104

IEV99

NOMESCO Finland

Other psychiatric network intervention

11.7

29.6

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

29.4

1074

7808

S76

ICPC

Skin infection other

3.2

29.2

165

545

J01DB01

ATC

cefalexin; oral

1.7

29.1

2199

19213

QCB00

NOMESCO Finland

Suture of skin of upper limb

5.1

29.0

186

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

81.0

28.8

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.6

28.7

230

949

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

151.6

28.7

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

28.7

135

390

SGA01

NOMESCO Finland

Tooth opening as first aid

1.9

28.7

522

3083

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.9

28.6

521

3077

OAB43

SPAT

0.5

28.3

203

4014

R18

ICD-10 Finland

Ascites

7.1

28.2

101

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

28.2

286

1333

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

8.2

28.1

ZXY49

NOMESCO Finland

Other health care provider

8.4

28.0

N07BA03

ATC

varenicline; oral

2.7

27.9

208

823

S51.8

ICD-10 Finland

Open wound of other parts of forearm

8.0

27.9

2920A

ICD-9 Finland

Drug psychoses, Drug withdrawal syndrome

284.3

27.8

WW200

NOMESCO Finland

Immunization

3.8

27.7

120

323

J01MA12

ATC

levofloxacin; systemic

1.9

27.4

418

2314

A28

ICPC

Limited function/disability NOS

2.4

27.1

250

1108

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.0

27.1

179

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

17.7

27.0

Z2445

NOMESCO Finland

Psychologist

3.0

27.0

162

560

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

7.4

27.0

R02

ICPC

Shortness of breath/dyspnoea

2.2

27.0

283

1339

Z72.0

ICD-10 Finland

Tobacco use

4.0

27.0

111

286

RS310

NOMESCO Finland

22.0

26.9

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.5

26.9

220

X84

ICD-10 Finland

Intentional self-harm by unspecified means

15.4

26.8

K04.1

ICD-10 Finland

Necrosis of pulp

2.1

26.8

334

1705

B18.8

ICD-10 Finland

Other chronic viral hepatitis

273.6

26.8

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.2

26.8

105

259

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

3.4

26.7

136

418

F15.9

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, unspecified mental and behavioural disorder

97.7

26.7

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

17.0

26.6

RS120

NOMESCO Finland

17.0

26.6

S29

ICPC

Skin symptom/complaint other

2.0

26.5

391

2136

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

26.4

208

847

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

11.6

26.4

Z01.7

ICD-10 Finland

Laboratory examination

2.2

26.3

301

1479

07007

ICD-8 Finland

Infectious hepatitis, Suspecta

+∞

26.1

3040A

ICD-9 Finland

Drug dependence, Opioid type dependence

+∞

26.1

ZXA05

NOMESCO Finland

Left side

1.8

26.0

545

3359

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.8

26.0

177

661

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.2

26.0

102

252

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

25.7

184

710

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

25.7

265

1242

F12.2

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, dependence syndrome

263.0

25.7

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.9

25.7

181

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

6.8

25.7

N02BE01

ATC

paracetamol; systemic, rectal

1.6

25.6

2174

19122

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.8

25.5

175

659

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

13.5

25.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

25.1

432

2487

3017A

ICD-9 Finland

Personality disorders, Antisocial personality disorder

58.6

25.0

W25

ICD-10 Finland

Contact with sharp glass

6.6

24.9

101

EBA00

SPAT

4.8

24.8

179

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

70.5

24.8

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.1

24.7

249

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

4.4

24.7

216

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

24.7

216

934

O35.4

ICD-10 Finland

Maternal care for (suspected) damage to fetus from alcohol

131.2

24.6

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

10.4

24.5

SPAT1234

SPAT

Support of social functional capacity

3.3

24.5

126

391

QCA10

NOMESCO Finland

Incision of skin of upper limb

17.5

24.4

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

24.2

176

687

L03

ICPC

Low back symptom/complaint

1.7

24.1

597

3860

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

24.1

166

626

K04.09

ICD-10 Finland

Pulpit UNS

2.8

24.0

164

617

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

6.3

24.0

103

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

5.1

23.8

152

R4120

NOMESCO Finland

Occupational therapy

2.6

23.6

179

715

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

4.2

23.6

226

F19.03

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances with delirium

126.1

23.6

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.0

23.6

158

R06.0

ICD-10 Finland

Dyspnoea

1.7

23.6

514

3198

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.5

23.6

129

M54.5

ICD-10 Finland

Low back pain

1.6

23.5

847

6047

JN4BD

NOMESCO Finland

Extensive body CT

2.2

23.5

242

1132

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

23.4

125

399

N06AX05

ATC

trazodone; oral

3.8

23.3

101

273

SPAT1260

SPAT

Consultation of another employee

1.8

23.3

419

2449

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

6.9

23.3

W19

ICD-10 Finland

Unspecified fall

2.2

23.1

247

1176

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

4.5

23.1

193

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

12.6

23.1

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.9

23.0

364

2032

RS140

NOMESCO Finland

18.6

23.0

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.4

23.0

133

F11.00

ICD-10 Finland

Intoxication caused by opiates uncomplicated

+∞

22.9

B17.2

ICD-10 Finland

Acute hepatitis E

+∞

22.9

K04.08

ICD-10 Finland

Other specified pulpit

2.2

22.9

238

1117

SGC10

NOMESCO Finland

Covering pulpa of tooth

2.0

22.9

325

1743

IBZ03

NOMESCO Finland

Addiction psychiatry evaluation

65.5

22.8

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

8.5

22.8

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

22.7

1446

11713

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

22.7

1920

16544

Z09

ICPC

Legal problem

11.5

22.7

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

17.7

22.6

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

12.7

22.6

F22.0

ICD-10 Finland

Delusional disorder

4.9

22.6

153

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

9.2

22.5

SPAT1283

SPAT

Restricted health certificate

1.7

22.5

595

3911

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

22.4

700

4807

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

13.2

22.4

R41.0

ICD-10 Finland

Disorientation, unspecified

4.5

22.4

181

A41.8

ICD-10 Finland

Other specified sepsis

6.6

22.4

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.0

22.3

146

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.1

22.3

264

1314

EB1AA

SPAT

2.8

22.2

151

565

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

14.4

22.1

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

22.1

1590

13183

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.5

22.0

107

318

D97

ICPC

Liver disease NOS

9.9

22.0

J01CF05

ATC

flucloxacillin; systemic

3.1

21.9

125

418

F19.51

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid

63.0

21.9

X58

ICD-10 Finland

Exposure to other specified factors

1.8

21.8

413

2451

N05AF01

ATC

flupentixol; systemic

5.3

21.8

129

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

3.2

21.7

115

365

L03AA04

ATC

39.0

21.7

Z04.6

ICD-10 Finland

General psychiatric examination, requested by authority

22.4

21.7

C02AC01

ATC

clonidine; systemic

22.4

21.7

-50

ICPC

Medication/prescr/renewal

3.2

21.7

119

388

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

6.3

21.7

SPAT1274

SPAT

Brief intervention in person with addiction symptoms

12.8

21.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.2

21.5

131

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021879) Hepatitis B virus core Ab [Presence] in Serum

909

2479

4.80

312.82

1.8

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

485

738

7.63

312.44

1.2

1.3

titre

89.7

0.00

(3028707) Methadone [Presence] in Urine by Screen method

725

696

13.36

307.65

12.1

2.2

—

(4198724)

290

178

17.90

307.65

5.7

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

877

1935

5.96

307.65

2.9

2.3

g/l

0.2

19.75

797

1816

(3027944) Amphetamines [Presence] in Urine

865

1695

6.73

307.65

11.7

1.7

—

(3011288) Drugs identified in Urine by Screen method

876

1128

10.50

307.65

16.2

2.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2065

8338

5.59

307.65

5.9

3.3

u/l

54.7

33.4

10.13

1964

7940

(3016879) Cocaine [Presence] in Urine

884

1600

7.38

307.65

12.2

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

1570

5721

4.60

307.65

6.4

4.0

89.1

93.5

10.10

1525

5570

(3000764) Benzodiazepines [Presence] in Urine

888

1719

6.88

307.65

12.4

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2008

8942

4.66

307.65

6.0

5.1

g/l

36.0

36.6

3.50

1905

8396

(3027008) Opiates [Presence] in Urine

882

1730

6.77

307.65

11.8

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2342

11368

5.60

307.65

8.7

6.1

umol/l

12.6

11.3

3.03

2254

10807

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

560

+∞

307.65

1.2

0.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1633

6447

4.31

307.65

2.6

1.9

—

(3028300) Cannabinoids [Presence] in Urine

889

1735

6.83

307.65

12.6

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1254

3773

4.95

307.65

1.9

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1311

4226

4.69

307.65

3.2

1.8

1.6

1.4

23.20

1175

3802

(1001926) Buprenorphine [Presence] in Urine by Screen method

836

1336

8.25

307.65

12.0

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1569

5108

5.28

307.65

2.1

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

930

129

103.38

307.65

2.1

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

850

150.82

307.65

2.1

1.3

iu/ml

1634228.3

—

138

(3016650) Hepatitis A virus Ab [Presence] in Serum

383

472

9.14

294.59

1.2

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

31.30

274.37

3.9

1.2

iu/ml

25385001.8

—

(3042517) Benzodiazepines panel - Urine

149

60.21

266.98

5.6

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

470

8.55

263.54

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

512

1074

5.53

236.26

1.5

1.4

—

(42870588) Differential panel, method unspecified - Blood

1637

7818

3.37

235.41

7.3

6.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2659

17587

5.06

221.33

11.3

7.2

u/l

84.5

75.1

15.64

2580

16686

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

797

2619

3.77

203.87

3.7

2.9

umol/l

12.2

7.4

4.14

672

2267

(40758558) Short blood count panel - Blood

1308

5861

3.16

202.15

9.8

7.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

376

692

6.06

198.56

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

689

2190

3.77

183.43

3.1

2.7

u/l

31.2

62.5

0.83

612

1910

(44816559) Phosphatidylethanol [Mass/volume] in Blood

345

630

6.05

183.27

2.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

199

191

11.08

182.77

7.1

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

225

257

9.37

182.12

1.1

—

(3022096) Basophils/100 leukocytes in Blood

1906

10942

2.99

182.08

8.5

6.3

0.7

0.66

1818

10328

(3019069) Monocytes/100 leukocytes in Blood

1948

11356

2.99

180.10

8.8

6.5

8.5

0.23

1862

10758

(3006504) Eosinophils/100 leukocytes in Blood

1935

11287

2.96

177.79

8.6

6.3

2.7

2.8

0.92

1844

10634

(3013650) Neutrophils [#/volume] in Blood by Automated count

2198

13759

3.15

177.07

15.7

9.2

e9/l

4.0

0.77

1966

12120

(3006315) Basophils [#/volume] in Blood

2021

12097

3.00

176.40

8.9

6.2

e9/l

0.0

0.71

1776

10617

(3023183) Ammonium ion [Moles/volume] in Plasma

290

462

6.83

176.34

3.4

3.3

umol/l

37.8

36.4

0.23

260

407

(3001604) Monocytes [#/volume] in Blood

2016

12062

2.99

175.89

9.0

6.1

e9/l

0.6

2.50

1774

10603

(3013115) Eosinophils [#/volume] in Blood

2058

12504

3.00

173.46

10.0

6.4

e9/l

0.2

0.83

1821

11172

(3023368) Bacteria identified in Blood by Culture

1174

5309

2.97

173.06

7.0

4.3

—

(3009508) Creatinine [Moles/volume] in Urine

1355

6635

2.88

171.98

10.3

3.2

mmol/l

7.2

8.5

16.83

1193

5736

(3002030) Lymphocytes/100 leukocytes in Blood

1965

11774

2.89

167.61

8.7

6.2

30.4

29.0

6.11

1871

11122

(3019198) Lymphocytes [#/volume] in Blood

2038

12487

2.91

165.84

9.0

6.2

e9/l

2.1

2.0

2.26

1815

11185

(3018010) Neutrophils/100 leukocytes in Blood

1936

11609

2.84

163.08

8.5

6.0

54.8

56.5

7.88

1846

10994

(3021589) Normoblasts [#/volume] in Blood

1819

10629

2.77

160.07

12.6

8.9

e9/l

0.0

0.38

1518

8730

(3006922) Hepatitis E virus Ab [Presence] in Serum

171

193

9.33

139.29

1.1

—

(3032080) INR in Blood by Coagulation assay

1449

7964

2.56

137.95

7.2

7.5

inr

1.1

1.2

2.17

444

2485

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1566

9070

2.50

131.23

7.9

6.2

mmol/l

1.2

7.12

1452

8314

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

160

179

9.38

131.14

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

323

745

4.73

130.61

1.2

1.3

titre

478.0

1382.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

159

179

9.32

129.69

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

583

2071

3.25

126.68

4.5

3.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

187

267

7.40

125.22

27.9

19.5

nmol/l

1384.1

1403.9

0.11

180

260

(3030467) Casts [#/volume] in Urine by Automated count

1141

5847

2.52

122.77

3.4

2.9

e6/l

0.5

0.4

0.83

848

4350

(3018095) Leukocytes [#/volume] in Urine

1371

7675

2.43

121.06

4.1

3.5

e6/l

51.0

64.4

0.62

941

5305

(3013826) Glucose [Moles/volume] in Serum or Plasma

1967

12993

2.45

118.28

7.3

4.8

mmol/l

6.6

0.24

1859

12049

(36304419) Bacteria [Presence] in Urine

1126

5829

2.48

117.47

3.3

2.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1641

10047

2.37

116.84

8.7

6.8

mmol/l

1.2

9.62

1415

8558

(3002582) Erythrocytes [#/volume] in Urine

1201

6446

2.43

115.17

3.4

3.0

e6/l

80.6

94.4

0.12

900

4905

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

203

348

6.18

114.08

3.3

3.4

u/ml

6204.2

88.3

0.73

198

324

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2480

18531

2.83

110.35

6.7

3.0

u/l

68.9

45.5

18.62

2383

17681

(3005719) IgG [Mass/volume] in Serum or Plasma

533

1938

3.12

110.26

2.3

2.6

g/l

12.8

10.4

21.05

504

1783

(3020191) Ethanol [Moles/volume] in Serum or Plasma

169

252

7.04

108.64

1.8

1.6

promille

1.3

1.5

0.42

131

198

(3007463) Buprenorphine [Presence] in Urine

111

230.30

108.39

10.3

3.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

504

1802

3.15

107.12

4.6

4.0

kpa

5.9

0.22

477

1757

(3018418) pH of Serum or Plasma

1113

5935

2.38

106.55

4.2

4.1

7.4

1.64

185

1152

(3002032) Base excess in Venous blood by calculation

500

1790

3.15

105.96

4.6

4.0

mmol/l

1.6

2.0

1.37

397

1453

(3028026) IgM [Mass/volume] in Serum or Plasma

448

1511

3.30

104.84

1.4

1.8

g/l

1.6

1.3

3.18

418

1405

(3000991) Gas panel - Venous blood

478

1699

3.15

102.34

10.3

9.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

636

2650

2.77

101.99

7.4

6.7

mmol/l

1.0

0.02

605

2485

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

344

1000

3.75

101.19

4.2

mmol/l

23.9

24.3

1.30

306

917

(3042936) Bacteria identified in Isolate by Culture

702

3091

2.65

100.82

2.6

2.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1225

6963

2.27

99.36

3.9

2.6

u/l

56.2

57.3

0.24

1122

6517

(3014111) Lactate [Moles/volume] in Serum or Plasma

486

1835

2.96

93.07

9.5

7.9

mmol/l

1.4

0.46

466

1765

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

722

3340

2.52

92.74

2.9

2.8

e6/l

3.3

2.2

1.89

363

1770

(3037522) Nuclear Ab [Titer] in Serum

739

3482

2.48

91.06

1.4

titre

343.3

488.8

1.99

153

657

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

746

3543

2.46

90.25

2.8

2.6

e6/l

2.0

1.0

0.95

385

1962

(3027974) Hepatitis B virus e Ag [Presence] in Serum

111.31

89.47

2.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

413

1455

3.13

89.14

4.2

3.1

kpa

5.1

4.7

2.86

387

1415

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1312

7920

2.15

89.04

2.0

1.8

pmol/l

96.3

96.6

0.06

690

4379

(3013945) Hepatitis B virus e Ab [Presence] in Serum

135.48

86.46

2.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

334

1055

3.43

86.14

1.4

1.3

miu/ml

183.6

219.3

0.77

108

506

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1092

6238

2.17

84.34

2.8

2.1

u/l

360.1

258.5

1.06

1031

5915

(3031040) Bacteria [#/volume] in Urine by Automated count

2008

14463

2.14

83.12

4.8

3.8

e6/l

410.6

963.4

0.61

174

(3015736) pH of Urine

1394

8815

2.07

81.59

5.6

2.9

—

5.7

—

(3026782) Osmolality of Urine

798

4073

2.30

80.79

3.0

2.6

mosm/kgh2o

536.2

557.0

1.55

689

3485

(3012095) Magnesium [Moles/volume] in Serum or Plasma

698

3374

2.39

80.08

4.0

3.7

mmol/l

0.8

6.00

647

3192

(3007853) Bacteria identified in Skin by Aerobe culture

592

2699

2.48

77.03

2.1

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

111

152

7.54

76.87

13.7

8.1

u/ml

1082.7

14707.8

0.47

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

506

2167

2.60

74.98

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

511

2201

2.59

74.82

2.1

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

559

2514

2.50

74.72

9.9

7.6

mmol/l

104.6

104.4

0.58

543

2466

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

651

3182

2.33

71.98

2.1

1.8

—

(3003396) Base excess in Arterial blood by calculation

507

2218

2.54

71.64

10.1

8.9

mmol/l

0.7

1.0

0.59

408

1737

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

14.94

70.84

2.5

3.5

mg/l

9.3

79.0

—

(3000850) Epithelial cells [#/volume] in Urine

807

4374

2.15

68.88

2.7

2.5

e6/l

10.8

5.4

1.70

716

3857

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

107

8.54

68.71

1.6

3.0

umol/l

156.5

132.9

0.20

(3022217) INR in Platelet poor plasma by Coagulation assay

499

2211

2.50

68.41

11.4

18.2

inr

1.1

1.2

3.13

343

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

494

2219

2.46

65.56

10.3

8.9

kpa

5.3

5.1

3.45

471

2128

(3027801) Oxygen [Partial pressure] in Arterial blood

494

2219

2.46

65.56

10.3

8.9

kpa

11.7

12.8

4.81

472

2132

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

232

692

3.55

64.96

2.3

2.4

ug/l

670.5

428.3

0.63

219

649

(3019550) Sodium [Moles/volume] in Serum or Plasma

2841

24601

3.33

64.87

23.4

12.7

mmol/l

139.0

139.7

40.66

2786

23998

(3020779) Urea [Moles/volume] in Serum or Plasma

425

1798

2.59

63.95

7.8

8.7

mmol/l

8.4

8.6

0.19

408

1735

(3023103) Potassium [Moles/volume] in Serum or Plasma

2845

24698

3.33

63.79

23.4

12.8

mmol/l

4.0

0.11

2786

24037

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

294

1036

3.03

62.61

12.0

11.5

mmol/l

24.3

0.07

275

987

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

567

2765

2.29

62.17

2.4

2.5

22.7

24.4

1.38

495

2396

(3015377) Calcium [Moles/volume] in Serum or Plasma

1090

6787

1.94

62.15

3.2

mmol/l

2.3

2.4

0.47

950

6105

(3004789) Transferrin [Mass/volume] in Serum or Plasma

594

2990

2.23

60.15

2.4

g/l

2.4

0.75

541

2790

(3019150) Specific gravity of Urine by Refractometry

844

4885

2.01

58.93

7.0

3.4

kg/l

1.0

1.17

657

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

721

3944

2.09

58.81

3.7

3.3

ng/l

246.5

486.5

2.05

479

2677

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

101

168

6.18

58.25

3.1

2.8

35.5

43.4

2.74

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

290

1055

2.93

58.23

1.9

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

614

3186

2.16

57.35

2.5

2.3

30.7

29.6

3.53

601

3081

(3021960) Folate [Moles/volume] in Serum or Plasma

765

4324

2.03

56.79

1.6

1.5

nmol/l

18.7

20.1

2.20

685

3804

(3037467) Urinalysis macro (dipstick) panel - Urine

2049

15873

1.89

56.76

4.7

3.8

—

(40768441) Liver Pathology biopsy report

100

173

5.94

55.42

1.4

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

169

460

3.83

54.05

5.6

6.1

umol/l

356.1

376.8

0.99

147

404

(3013707) Erythrocyte sedimentation rate by Westergren method

2175

17300

1.90

53.96

4.2

3.8

mm/h

12.9

9.6

18.13

2016

16247

(3044640) Blood type and Crossmatch panel - Blood

1082

6965

1.86

53.94

3.0

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

856

5114

1.94

53.69

2.4

2.1

mg/l

3.0

2.8

0.96

738

4412

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

628

3365

2.09

53.56

2.9

mmol/l

2.4

2.87

528

2969

(3002385) Erythrocyte distribution width [Ratio]

2545

21407

2.15

53.25

29.8

14.1

13.8

13.5

20.50

2521

20982

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

730

4147

2.00

52.92

2.6

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

607

3226

2.10

52.84

2.3

2.5

umol/l

13.6

14.2

1.08

564

3012

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

455

2156

2.31

52.75

3.5

4.5

u/l

238.1

240.9

0.13

429

2052

(3023511) Choriogonadotropin [Units/volume] in Urine

202

629

3.37

52.73

1.7

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

410

1861

2.39

52.46

11.4

9.7

g/l

121.1

125.1

3.09

400

1803

(3016502) Oxygen saturation in Arterial blood

425

1984

2.33

50.91

11.3

9.5

95.3

96.1

1.89

416

1920

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

777

4590

1.93

49.83

2.8

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

112

238

4.85

49.44

1.3

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

148

391

3.93

49.34

3.2

2.1

titre

1950.8

1365.9

0.30

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

142

6.13

48.80

2.6

2.2

nmol/l

145.7

153.8

0.25

122

(3026008) Bacteria identified in Urine by Culture

858

5268

1.88

48.70

3.5

2.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

414

1958

2.29

47.94

2.9

2.8

1.9

1.8

0.87

356

1769

(3052851) Hemolysis interference index of Serum or Plasma

192

617

3.25

47.57

2.9

3.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2680

23279

2.27

47.32

18.7

10.4

ml/min/173m2

93.7

89.6

16.38

2273

19199

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2811

24979

2.64

46.22

21.7

11.7

mg/l

24.0

21.9

2.82

2379

19328

(3019309) Folate [Moles/volume] in Red Blood Cells

576

3151

2.02

45.70

1.8

1.7

nmol/l

1100.8

1167.7

0.97

435

2473

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

291

1206

2.56

45.06

1.6

1.5

—

(1761868) Lipid panel - Serum or Plasma

676

10648

0.53

44.94

2.8

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

844

5288

1.82

44.17

2.8

2.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

144

409

3.65

43.23

2.6

3.1

u/ml

700.7

1842.9

0.58

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

172

551

3.25

42.80

4.2

6.5

iu/ml

1165.1

681.8

0.40

(3011397) Hemoglobin [Presence] in Urine by Test strip

808

5040

1.82

42.67

3.3

3.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

197

689

2.99

42.20

4.3

3.6

mg/l

1.4

0.06

191

647

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

215

4.68

41.63

2.3

2.9

e6/l

837.1

713.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

215

4.68

41.63

1.2

titre

326.0

227.3

0.31

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

102

232

4.51

41.44

13.0

12.4

mmol/l

0.6

0.27

211

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

12.21

41.07

8.0

11.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

816

5178

1.79

40.33

1.5

g/l

2.6

2.4

2.56

532

3415

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2557

22160

1.96

40.15

5.2

4.4

mu/l

1.8

2.0

1.16

2372

20758

(21491868) Cryoglobulin [Mass/volume] in Serum

102

6.39

38.50

1.6

1.1

g/l

0.3

0.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

8.85

38.43

1.3

—

(3017509) Phencyclidine [Presence] in Urine

10.92

38.22

4.6

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

254

1076

2.48

37.38

12.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

109

290

3.86

35.97

6.2

7.0

mg/l

9.9

10.5

0.71

101

268

(3029634) Reagin Ab [Titer] in Serum by VDRL

146

471

3.21

35.88

4.1

2.5

titre

13.9

3.0

0.44

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

132

401

3.40

35.75

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

132

401

3.40

35.75

1.3

—

(21494755) Public health laboratory ask at order entry panel

158

3985

0.36

35.64

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

131

399

3.39

35.33

1.8

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

177

644

2.86

35.24

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

165

584

2.93

34.55

1.3

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2902

26833

2.76

32.30

17.3

9.1

u/l

43.7

29.1

28.82

2866

26114

(3004119) Hemoglobin [Mass/volume] in Venous blood

253

1144

2.32

32.09

4.7

3.3

g/l

130.9

133.0

0.67

247

1121

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

194

783

2.58

31.53

1.7

1.9

g/l

1.4

1.5

0.36

157

683

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

153

550

2.88

31.13

1.3

1.5

u/ml

115.4

116.1

0.02

102

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

164

612

2.78

31.12

1.3

1.2

u/ml

268.9

252.1

0.29

127

389

(3024928) Oxygen saturation in Venous blood

132

440

3.09

30.70

4.3

3.3

—

(3044889) 12 lead EKG panel

1952

16156

1.58

30.63

3.8

3.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1230

9176

1.57

30.62

2.5

2.3

nmol/l

69.7

73.7

4.92

1132

8500

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

9.12

30.37

2.8

4.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

201

841

2.49

30.28

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

119

376

3.25

30.27

1.1

g/l

1.7

1.4

5.69

108

341

(3037121) Protein [Mass/volume] in Urine

184

741

2.58

30.03

4.4

3.4

g/l

0.3

0.31

128

349

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1381

10691

1.53

28.42

4.6

3.9

—

(3036180) Methadone [Presence] in Urine

55.57

28.16

5.2

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

157

617

2.63

26.92

1.9

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2156

18503

1.57

26.70

4.1

3.8

pmol/l

14.5

14.6

0.75

1977

17176

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

176

735

2.48

26.60

3.2

2.8

g/l

3.5

3.6

0.39

171

692

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

198

880

2.34

26.07

4.5

2.9

0.6

0.7

0.50

193

846

(40768797) Stomach Pathology biopsy report

495

3062

1.74

25.33

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.40

24.95

3.2

3.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

221

1049

2.19

24.85

1.3

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

271

1395

2.03

24.64

2.5

2.8

e9/l

76.1

72.6

0.56

178

1043

(3035350) Ketones [Presence] in Urine by Test strip

1430

11406

1.48

24.01

3.6

3.1

estimate

0.0

0.80

293

2120

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

153

3344

0.43

23.79

1.5

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1428

11418

1.47

23.49

5.1

4.3

estimate

0.0

0.50

298

2193

(3009261) Glucose [Presence] in Urine by Test strip

1436

11528

1.47

22.94

3.6

3.2

estimate

0.0

1.22

293

2086

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1347

10685

1.47

22.87

3.1

2.8

ug/l

133.8

116.7

1.12

1235

10081

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

396

2377

1.77

22.34

2.6

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

838

6065

1.53

22.23

1.6

mmol/l

1.6

1.5

1.80

751

5243

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

143

592

2.49

22.03

2.6

2.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

329

1880

1.84

21.85

2.6

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

761

5417

1.54

21.72

2.0

1.8

mg/l

1.4

1.0

1.18

585

3965

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

182

3.74

21.54

3.5

4.3

—

(3000494) Fungus identified in Specimen by Culture

445

2807

1.69

20.91

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

150

654

2.36

20.63

3.3

3.9

u/ml

89.3

2248.7

0.80

127

562

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

270

1480

1.90

20.39

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

180

854

2.18

20.24

4.6

3.5

mmol/l

24.9

25.2

0.61

174

828

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

244

1304

1.95

19.87

2.8

2.5

u/l

4931.3

5697.8

0.14

523

(3000093) Morphology [Interpretation] in Blood Narrative

176

3.63

19.47

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

161

743

2.23

19.39

5.2

2.6

183.6

176.4

0.41

154

709

(3021387) Prolactin [Units/volume] in Serum or Plasma

239

1284

1.93

19.15

1.7

1.6

mu/l

361.5

282.8

2.26

199

1169

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

172

827

2.14

18.71

3.2

2.4

84.0

94.1

5.70

165

772

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

105

406

2.64

18.65

1.5

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

120

501

2.45

18.19

1.9

2.1

g/l

0.0

0.76

109

470

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

114

466

2.50

18.08

1.7

2.1

g/l

0.0

0.00

103

435

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

128

553

2.37

17.99

2.2

g/l

0.6

0.9

0.32

111

499

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

156

733

2.19

17.98

2.5

2.1

ug/l

1.3

1.7

0.45

141

668

(3020630) Protein [Mass/volume] in Serum or Plasma

256

1437

1.85

17.92

2.2

2.5

g/l

67.6

67.3

0.25

233

1344

(3010421) pH of Blood

131

576

2.33

17.70

4.5

3.9

7.4

4.67

113

476

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2537

23235

1.55

17.65

4.8

3.8

mmol/l

6.1

5.8

10.81

2341

21711

(40761511) CBC panel - Blood by Automated count

2811

26436

1.83

17.41

19.6

10.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

119

507

2.40

17.27

1.7

2.1

g/l

37.7

38.3

0.39

104

451

(3012501) Base excess in Blood by calculation

115

484

2.43

17.14

4.6

4.0

mmol/l

2.1

2.3

0.31

315

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

111

463

2.45

16.88

1.7

2.2

g/l

0.0

0.00

103

434

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

195

3.28

16.68

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

115

4.05

16.65

1.2

1.1

iu/ml

5.4

4.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

649

2.20

16.29

2.2

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

649

2.20

16.29

2.2

2.0

g/l

3.7

3.9

0.76

108

478

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

649

2.20

16.29

2.2

2.0

g/l

7.4

7.2

0.45

108

504

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

597

2.25

16.29

1.9

2.0

g/l

12.9

10.4

4.21

115

519

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

216

3726

0.55

16.23

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.67

16.10

4.8

2.3

—

(1616796) Gas panel - Central venous blood

107

457

2.39

15.47

4.2

3.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

987

7806

1.39

15.20

3.9

3.1

ng/l

53.3

43.1

0.18

596

4523

(3009214) Lutropin [Units/volume] in Serum or Plasma

198

1079

1.89

15.19

1.4

u/l

7.9

7.8

0.02

139

873

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

106

2263

0.45

15.16

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

215

1207

1.84

15.03

10.1

8.2

mmol/l

24.6

24.4

0.30

203

1131

(3009542) Hematocrit [Volume Fraction] of Blood

2626

24428

1.55

14.97

27.0

12.2

40.1

41.2

10.74

2011

19722

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

8.05

14.89

1.9

1.1

mg/l

64.6

43.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

124

576

2.20

14.74

3.1

3.7

u/ml

0.3

0.77

309

(40767503) Oxygen content in Capillary blood by calculation

422

2.39

14.40

3.2

2.5

16.5

17.2

0.81

211

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

615

2.15

14.38

2.1

2.0

g/l

3.1

0.13

108

489

(3013762) Body weight Measured

9.49

14.33

1.1

1.3

—

(3051651) Icteric interference index of Serum or Plasma

133

3.57

14.33

3.1

3.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.19

14.20

1.6

1.3

g/l

93.2

23.3

0.41

(3012516) Albumin [Mass/volume] in Urine

751

5724

1.41

14.18

3.4

3.3

mg/l

287.2

378.4

0.27

472

3780

(3020682) Albumin/Creatinine [Ratio] in Urine

781

5994

1.41

14.17

4.2

4.1

mg/mmol

19.8

9.8

2.29

492

3958

(3036489) Thrombin time

174

936

1.91

13.89

3.2

2.3

22.6

21.1

3.33

160

814

(3011648) Oxygen content in Venous blood

173

3.16

13.57

4.4

2.6

11.3

0.01

173

(3028308) Erythrocytes [#/volume] in Pleural fluid

143

3.39

13.55

1.6

1.4

e6/l

29627.3

72805.6

0.48

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

4.13

13.47

2.2

2.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

111

513

2.21

13.39

4.1

4.0

53.9

56.5

1.57

111

513

(3045788) Cell count panel - Pleural fluid

130

3.50

13.32

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

160

3.22

13.27

1.6

1.4

e6/l

25057.3

2189.9

0.57

111

(3044007) Cell count panel - Peritoneal fluid

4.95

13.09

3.1

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

503

3614

1.47

12.94

2.0

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

4.30

12.65

2.5

e6/l

259.9

753.5

1.74

(3033799) Differential panel - Peritoneal fluid

4.94

12.62

2.7

2.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

271

1709

1.64

12.52

3.4

4.3

ug/l

8.9

22.2

1.24

233

1356

(3012441) Differential panel - Pleural fluid

148

3.21

12.18

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

393

2.30

12.00

1.4

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

197

1155

1.75

11.93

2.0

2.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.55

11.88

2.6

2.3

e6/l

690.4

30102.1

0.55

(3006184) Hemoglobin [Mass/volume] in Capillary blood

434

2.23

11.83

2.4

2.2

g/l

129.9

134.6

0.92

318

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

618

4682

1.40

11.80

2.9

ng/l

1684.5

1047.3

0.87

508

3855

(3019060) Gas panel - Arterial blood

206

1235

1.72

11.53

7.2

5.9

—

(3051611) Lipemic interference index of Serum or Plasma

186

2.88

11.43

3.2

3.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

224

1387

1.66

11.11

4.3

ng/l

96.5

85.8

0.88

200

1251

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

232

2.62

10.79

2.4

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

380

2676

1.48

10.72

2.6

2.3

nmol/l

13.6

0.05

316

2446

(3003181) Sodium [Moles/volume] in Urine

306

2.39

10.63

1.6

1.3

mmol/l

50.1

66.5

1.97

253

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

138

756

1.86

10.48

6.4

6.7

2.4

1.7

4.53

129

710

(3017181) Myelocytes/100 leukocytes in Blood

286

1907

1.55

10.44

4.6

4.4

0.6

0.9

1.38

105

520

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.62

10.35

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.62

10.35

1.4

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

205

1269

1.66

10.19

3.6

3.3

kpa

5.3

5.2

1.78

191

1190

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

197

1207

1.68

10.19

3.6

3.3

mmol/l

1.7

1.5

0.35

147

895

(40761536) Microorganisms panel - Urine sediment

296

2005

1.53

10.06

4.0

3.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

484

2.06

10.06

2.2

3.3

mg/l

54.2

71.5

0.50

386

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

472

2.07

9.97

2.2

3.3

ratio

3.7

2.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

243

1581

1.58

9.87

4.5

3.8

mmol/l

1.2

2.19

216

1383

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

105

537

1.99

9.80

1.5

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1787

0.51

9.79

1.7

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

484

2.04

9.69

2.2

3.3

mg/l

41.5

49.0

0.22

386

(3009343) pH of Capillary blood

201

1255

1.64

9.67

3.6

3.3

7.4

1.06

161

(3029937) Albumin [Presence] in Urine by Test strip

743

5955

1.33

9.66

3.9

3.5

estimate

0.0

1.74

284

2119

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

215

1367

1.62

9.62

2.8

ng/l

172.4

155.4

0.22

192

1205

(40760888) Immunoglobulin light chains.free panel - Serum

366

2.19

9.57

2.4

3.3

—

(3021901) Oxygen saturation in Capillary blood

347

2.22

9.54

3.0

2.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

113

600

1.92

9.47

1.8

1.5

e6/l

32724.0

1391.9

0.49

490

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

113

600

1.92

9.47

1.8

1.5

e6/l

27.7

31.5

0.10

469

(3007930) Methemoglobin/Hemoglobin.total in Blood

134

752

1.82

9.45

6.6

6.7

0.9

0.29

125

708

(3029075) Extractable nuclear Ab panel - Serum

3.88

9.40

1.2

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.60

9.37

1.4

1.5

ug/l

12.5

8.1

2.67

(3000570) Elastase.pancreatic [Mass/mass] in Stool

116

625

1.89

9.30

1.4

ug/g

252.3

299.5

1.88

343

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2358

21972

1.33

9.29

5.8

4.8

mmol/mol

38.8

0.10

2197

20817

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

724

5816

1.32

9.20

1.3

u/ml

1.7

0.03

135

1664

(3002179) Metamyelocytes/100 leukocytes in Blood

261

1757

1.53

9.12

4.3

4.1

0.6

0.10

385

(3023420) DNA double strand Ab [Units/volume] in Serum

277

2.34

9.12

1.5

iu/ml

16.3

26.4

—

(3007461) Platelets [#/volume] in Blood

2937

28522

1.85

9.04

34.7

17.0

e9/l

239.2

253.6

21.40

2886

27924

(3015235) Bicarbonate [Moles/volume] in Capillary blood

497

1.98

9.03

3.5

2.8

mmol/l

24.8

24.7

0.08

437

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

362

2.16

9.02

1.1

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

101

530

1.94

8.79

1.7

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

265

1816

1.50

8.52

4.8

4.4

0.0

0.1

2.80

477

(3020891) Body temperature

135

785

1.75

8.48

8.2

4.9

—

(3035941) MCH [Entitic mass]

2937

28558

1.82

8.47

34.5

16.9

30.3

30.2

1.00

2919

28255

(3024731) MCV [Entitic volume]

2937

28558

1.82

8.47

34.6

16.9

90.5

90.2

3.66

2919

28258

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.89

8.41

1.7

1.1

98.6

92.3

0.45

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.89

8.41

1.7

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

2937

28563

1.81

8.39

34.7

17.0

e12/l

4.5

4.6

23.10

2876

27921

(3019977) pH of Arterial blood

3.25

8.34

3.0

3.1

7.4

—

(3010813) Leukocytes [#/volume] in Blood

2937

28574

1.80

8.22

34.8

17.0

e9/l

7.1

6.7

15.97

2878

27919

(3000963) Hemoglobin [Mass/volume] in Blood

2937

28575

1.80

8.21

34.9

17.1

g/l

135.9

139.4

28.40

2917

28270

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.11

8.18

2.5

2.3

—

(3025159) Blasts/100 leukocytes in Blood

252

1724

1.50

8.17

4.8

4.5

0.0

0.5

0.90

403

(3034274) Bile acid [Moles/volume] in Serum --fasting

391

2.05

8.13

3.1

2.3

umol/l

15.0

6.5

0.93

284

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

154

941

1.67

8.09

2.3

1.9

pmol/l

186.2

213.3

2.13

148

897

(40768806) Pleura Pathology biopsy report

152

2.72

8.09

1.5

—

(44806118)

268

2.26

8.00

1.7

1.6

—

(44790048)

268

2.26

8.00

1.7

1.6

—

(44790049)

268

2.26

8.00

1.7

1.6

—

(44790047)

268

2.26

8.00

1.7

1.6

—

(3003338) MCHC [Mass/volume]

2417

22775

1.30

7.58

31.3

14.4

g/l

333.4

334.2

3.74

2405

22611

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

381

2.02

7.58

1.4

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

181

2.51

7.57

3.6

2.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

308

2.13

7.52

1.4

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

107

604

1.80

7.47

1.2

1.3

mmol/l

3.8

3.7

0.15

569

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.47

7.33

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

2.47

7.33

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.47

7.33

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

194

1288

1.54

7.25

2.1

1.8

nmol/l

49.1

36.3

8.20

182

1258

(3036481) Cortisol [Moles/volume] in Serum or Plasma

313

2292

1.41

7.11

2.3

2.1

nmol/l

347.7

371.1

1.53

288

2122

(3039443) Prostate specific Ag panel - Serum or Plasma

666

0.33

7.09

1.4

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

187

2.43

7.09

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

187

2.43

7.09

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

187

2.43

7.09

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

100

563

1.80

7.06

1.9

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

104

594

1.78

7.00

7.1

4.5

mmol/l

3.8

3.9

0.46

563

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.20

6.97

2.5

2.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

126

762

1.68

6.93

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

115

682

1.71

6.80

1.3

1.4

mg/l

542.2

507.7

0.21

109

647

(3023410) Appearance of Cerebral spinal fluid

281

2.12

6.77

2.3

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.58

6.59

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.58

6.59

2.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

423

1.89

6.56

1.7

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

525

4209

1.30

6.55

1.3

iu/ml

33.9

28.4

0.58

177

1310

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

170

2.43

6.52

1.4

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

321

2.02

6.43

2.8

3.4

1.2

1.4

0.18

265

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.13

6.43

1.7

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

126

2.64

6.22

27.4

26.0

ug/l

103.1

118.5

0.80

103

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

222

1566

1.45

6.21

2.3

ug/l

10.2

7.7

0.53

191

1418

(3047181) Lactate [Moles/volume] in Blood

107

641

1.69

6.13

7.5

7.6

mmol/l

1.3

1.2

0.06

559

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

2.60

6.04

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

278

2057

1.39

5.95

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.12

5.89

1.5

2.3

umol/l

16.1

15.7

0.05

(40760892) CBC W Ordered Manual Differential panel - Blood

703

5911

1.25

5.87

6.9

4.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

441

1.81

5.80

1.6

1.7

g/l

0.7

0.8

0.52

343

(4281824)

180

2.30

5.78

1.3

1.1

—

(3013512) EKG study

667

5586

1.25

5.76

3.8

3.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.39

5.76

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

382

1.85

5.54

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

122

2.56

5.53

1.2

1.1

iu/ml

330.9

232.5

0.61

122

(3037756) Immunofixation for Serum or Plasma

326

1.92

5.50

1.3

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

198

2.19

5.44

3.1

2.1

12.7

13.5

0.14

(3039000) Anion gap in Blood

444

1.78

5.40

8.9

9.3

mmol/l

10.9

11.5

0.96

403

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

415

1.80

5.38

1.4

1.3

u/l

19.2

20.9

0.15

340

(3018572) Chloride [Moles/volume] in Blood

445

1.77

5.36

8.9

9.3

mmol/l

104.4

105.3

0.77

404

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.13

5.35

1.0

—

(4035726)

243

1791

1.39

5.34

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

101

2.69

5.33

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.57

5.32

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

107

2.63

5.31

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

119

2.54

5.28

3.2

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

241

1787

1.38

5.11

3.4

2.4

ml/min/173m2

67.9

74.8

1.42

100

637

(3025130) Human papilloma virus identified in Specimen

343

1.85

5.06

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

212

2.09

4.99

1.3

1.2

u/l

64.8

56.6

0.51

150

(3023323) Follitropin [Units/volume] in Serum or Plasma

196

1413

1.41

4.92

1.3

1.4

iu/l

26.4

22.9

0.70

142

1186

(3042111) Morphology [Interpretation] in Bone marrow Narrative

304

1.89

4.88

1.4

1.8

—

(3044941) Cell count panel - Synovial fluid

326

1.86

4.86

1.4

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

313

2440

1.32

4.78

8.9

5.8

—

(3011412) CD3 cells [#/volume] in Blood

257

1.96

4.78

3.1

2.7

e9/l

1.3

1.2

0.32

149

(3008757) Leukocyte morphology finding [Identifier] in Blood

216

2.05

4.77

2.7

3.9

—

(3016018) Differential panel - Cerebral spinal fluid

293

1.89

4.74

2.3

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

108

2.51

4.71

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

330

1.83

4.69

1.6

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.22

4.61

1.6

g/l

7.7

11.3

0.97

(3008295) Osmolality of Serum or Plasma

233

1.99

4.59

2.0

1.6

mosm/kgh2o

285.9

283.1

0.34

184

(3026493) Urate [Moles/volume] in Serum or Plasma

699

6010

1.21

4.59

2.7

2.4

umol/l

1349.7

4300.2

3.03

609

5385

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

311

1.85

4.58

1.4

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

430

1.71

4.54

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

415

1.73

4.54

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

10.02

4.52

1.1

mmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

291

1.87

4.51

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

292

1.86

4.47

1.3

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

4.01

4.43

2.8

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

111

733

1.53

4.38

1.3

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

127

2.30

4.19

1.2

1.4

nmol/l

148.0

140.4

0.35

127

(42529406) Shigella sp [Presence] in Stool by Culture

111

743

1.51

4.13

1.3

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

8.02

4.06

1.0

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

110

738

1.51

4.06

1.3

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

515

1.61

4.04

3.1

2.9

nmol/l

1.0

0.9

0.63

443

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

102

0.00

4.02

0.0

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

494

4154

1.23

4.02

1.7

1.6

pmol/l

37685208.4

29883888.3

0.11

406

3604

(3000475) Leukocytes [#/volume] in Synovial fluid

485

1.62

4.00

1.6

1.7

e6/l

14568.4

14569.2

0.00

346

(3000492) Spirometry study

341

2760

1.27

3.91

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

255

1.86

3.89

1.4

1.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

336

1.74

3.88

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

285

1.80

3.85

1.6

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

123

1738

0.70

3.82

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.01

3.81

1.6

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.01

3.81

4.8

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

206

1567

1.34

3.77

1.3

1.2

—

(4010399)

204

1551

1.34

3.75

1.4

—

(40761535) Cells panel - Urine sediment

215

1648

1.33

3.74

3.5

3.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.70

3.65

1.3

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

199

1514

1.34

3.65

2.6

3.4

pmol/l

4.5

4.6

0.17

169

1364

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.61

3.63

4.7

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.43

3.63

2.4

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

111

2.26

3.54

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

534

1.55

3.51

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.71

3.49

3.1

4.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

181

1.94

3.38

1.3

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

181

1.94

3.38

1.3

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

181

1.94

3.38

1.3

1.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

2.04

3.30

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

471

1.56

3.28

1.2

—

7.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

346

1.66

3.27

1.3

1.2

u/l

51.9

38.4

0.24

293

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

362

1.64

3.25

2.7

2.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

250

1.77

3.20

1.4

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

185

1.90

3.19

3.5

2.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

3.19

2.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

239

1.77

3.05

2.9

nmol/l

0.9

0.8

0.27

180

(40768446) Kidney Pathology biopsy report

119

2.11

3.04

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

634

0.56

3.04

1.2

1.1

u/ml

3.8

6.8

0.79

330

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.27

3.03

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

225

1.79

3.02

1.4

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

511

5862

0.85

2.99

3.4

3.3

23.7

21.1

1.95

177

2205

(3035320) C reactive protein [Mass/volume] in Body fluid

161

1.93

2.99

2.0

2.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

100

2.21

2.99

4.5

2.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

219

1.79

2.97

3.3

5.8

mmol/l

7.4

7.3

0.08

184

(3021788) Differential panel - Synovial fluid

372

1.60

2.95

1.5

1.6

—

(3036603) Volume of Urine

155

1.94

2.94

1.9

1.5

1696.6

2067.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

133

987

1.36

2.93

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1239

0.69

2.89

1.8

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

200

1.81

2.85

1.6

2.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

268

1.69

2.82

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.77

2.81

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

1.98

2.80

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.45

2.79

1.3

1.4

nmol/l

14.0

32.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

209

1.78

2.78

1.3

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

110

2.10

2.78

3.5

1.8

umol/l

1.9

2.0

0.10

103

(3011985) Renin [Units/volume] in Plasma

277

1.67

2.77

1.4

1.5

mu/l

95.4

55.2

0.43

251

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1005

0.67

2.76

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

549

1.47

2.75

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.21

2.73

7.0

1.7

155.6

155.2

0.01

(3022313) Gas panel - Capillary blood

123

913

1.36

2.73

3.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

196

1.79

2.71

2.7

3.4

50.8

55.2

0.41

139

(3024471) HLA-A [Type]

105

2.10

2.68

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

480

0.54

2.62

1.2

1.1

u/ml

9.4

4.2

0.43

194

(3019225) pH of Specimen

231

1879

1.25

2.61

3.9

4.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

290

1.63

2.60

2.0

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

178

1.81

2.55

2.7

1.6

—

(3002256) Pathology report gross observation

329

2787

1.20

2.51

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

599

0.60

2.51

1.1

u/ml

0.7

2.2

—

144

(3000060) B lymphocytes [#/volume] in Blood

2.27

2.50

1.4

2.2

e6/l

102.5

187.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

194

1.76

2.50

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.11

2.48

1.0

1.3

—

1314.0

—

(1002224) Polysomnography panel

115

1519

0.75

2.45

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.14

2.44

1.0

1.3

—

69.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

107

793

1.36

2.43

3.7

3.6

mmol/l

24.9

24.8

0.07

100

748

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.95

2.41

2.0

2.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

516

0.58

2.39

1.1

u/ml

4.1

3.8

0.04

197

(3043238) Trisomy 21 risk [Likelihood] in Fetus

784

0.66

2.38

1.6

1.5

—

(3024932) HLA-DR beta [Type]

104

2.03

2.36

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

600

0.61

2.35

1.2

1.1

u/ml

0.2

1.2

2.48

249

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.15

2.34

1.4

1.1

98.3

89.7

0.74

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

169

1.78

2.32

1.3

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

528

1.43

2.31

1.2

u/ml

57.1

44.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

694

0.64

2.30

1.2

1.1

u/ml

1.5

1.7

0.08

275

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

192

1.73

2.30

1.8

1.5

26.5

33.3

0.52

119

(3047352) Trisomy 18 risk [Likelihood] in Fetus

764

0.66

2.27

1.6

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.48

2.27

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

432

0.55

2.27

1.2

1.1

u/ml

0.1

0.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

193

1.72

2.26

2.1

2.9

e6/l

762.8

546.6

0.69

167

(3005033) Fetal Nuchal fold Thickness US

761

0.66

2.24

1.6

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

142

1.84

2.23

1.5

1.6

nmol/l

1.4

1.2

0.16

118

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

466

1.45

2.21

1.1

iu/ml

102.3

1099.0

0.52

129

(40768443) Skin Pathology biopsy report

119

911

1.32

2.21

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

100

2.01

2.20

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

377

1.49

2.18

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

250

1.61

2.15

2.0

2.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

199

0.40

2.15

2.5

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

199

0.40

2.15

5.0

6.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.17

2.14

2.5

2.6

umol/l

26.5

29.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

134

1048

1.29

2.14

3.3

2.7

e6/l

0.3

0.2

0.85

128

1017

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.10

2.12

1.5

1.3

97.2

89.5

0.50

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.21

2.11

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

175

1.72

2.09

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

221

1.64

2.09

2.5

2.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

284

1.56

2.08

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

5.01

2.07

1.2

1.1

u/l

12.2

14.9

—

(4212803)

4.01

2.04

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

931

0.71

2.03

1.5

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.11

2.02

4.1

2.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

930

0.71

2.01

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

743

0.68

2.01

1.8

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.01

2.00

2.1

3.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.82

2.00

6.6

6.3

mmol/l

5.7

6.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

928

0.72

1.99

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

926

0.72

1.97

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

257

1.56

1.95

1.7

2.0

nmol/l

17.9

19.9

0.68

243

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

455

1.42

1.92

1.3

u/ml

3.0

5.0

0.79

150

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

863

0.71

1.91

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.31

1.87

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

136

1.77

1.87

2.5

1.6

umol/l

17.9

27.8

1.14

128

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

268

1.54

1.87

1.2

1.5

pmol/l

280.9

318.3

0.41

207

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.09

1.86

1.5

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2023

19543

1.10

1.86

3.6

3.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2334

23930

0.89

1.85

3.9

3.5

mmol/l

1.4

0.90

2139

22618

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

121

954

1.28

1.85

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

177

1460

1.23

1.83

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.17

1.82

1.6

2.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.05

1.80

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

258

2994

0.85

1.77

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

514

1.37

1.76

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma

102

1.87

1.76

1.7

2.8

mmol/l

8.2

9.4

0.80

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.09

1.76

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

185

1.63

1.75

2.3

3.0

e9/l

0.2

0.38

164

(3026389) Candida sp identified in Specimen by Organism specific culture

281

1.50

1.74

1.9

1.3

—

(3045142) Bone marrow Pathology biopsy report

217

1.57

1.73

1.3

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.70

0.0

1.3

—

7.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

164

1.65

1.68

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

172

1.63

1.67

1.4

2.1

—

(3049717) Cytology report of Urine Cyto stain

626

1.32

1.63

2.6

2.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

639

0.70

1.60

1.3

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

619

1.32

1.60

1.2

u/ml

17.4

7.8

0.42

(3010144) Erythrocytes [#/volume] in Synovial fluid

190

1.58

1.60

1.5

1.4

e6/l

57495.6

75016.4

0.15

134

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

612

1.32

1.57

1.2

u/ml

3.7

2.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.82

1.57

1.8

1.3

2.0

4.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

440

1.37

1.56

1.0

1.1

106.5

116.2

1.68

409

(3003694) ABO and Rh group [Type] in Blood

792

7369

1.10

1.55

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

961

9024

1.09

1.55

4.0

3.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.89

1.54

1.3

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.89

1.54

1.3

2.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.28

1.53

1.4

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

115

1.74

1.52

1.5

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

217

1.53

1.51

1.8

2.1

mg/l

22.5

21.1

0.06

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

391

4349

0.88

1.50

2.4

2.5

ug/l

0.5

0.7

3.99

262

2392

(3035880) pH of Pleural fluid

1.95

1.48

1.3

—

(3042733) HLA Ab [Presence] in Serum

109

1.75

1.46

2.3

4.9

—

(4034850)

745

1.27

1.44

12.1

8.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.73

1.43

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.73

1.43

1.3

1.0

—

(40757373) Influenza virus identified in Isolate

2.25

1.40

1.4

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.42

1.39

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

134

1.65

1.39

2.1

1.5

u/l

6.1

5.2

0.09

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.90

1.39

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

198

1.52

1.37

3.3

3.4

mg/l

87.8

82.3

0.04

148

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.34

1.1

—

(4268621)

317

1.39

1.31

2.1

2.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.30

1.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.10

1.30

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

482

1.31

1.29

1.2

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.78

1.28

1.2

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

758

1.25

1.28

1.7

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1202

0.81

1.28

1.5

1.7

mg/l

4.4

3.9

0.24

831

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

243

1.45

1.27

1.7

1.6

68.0

56.3

0.84

150

(3050129) First trimester maternal screen panel - Serum or Plasma

1133

0.81

1.25

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

968

9167

1.08

1.25

2.0

1.9

—

(3017569) Oxygen content in Arterial blood

1.77

1.23

2.8

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

434

1.32

1.22

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

280

1.40

1.20

2.7

3.7

u/ml

20.5

24.6

0.32

272

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

453

1.31

1.19

1.3

u/ml

4.4

4.9

0.10

207

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.75

1.19

1.3

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.31

1.18

1.7

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.15

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

1.15

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.81

1.15

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.96

1.11

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

380

1.32

1.10

3.6

3.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2437

24772

0.92

1.10

4.3

3.9

mmol/l

1.3

1.4

16.37

2247

23463

(3000012) Reticulocyte production index

1.67

1.10

1.3

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

112

1.61

1.08

1.1

1.0

ng/l

767.5

791.2

0.10

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

136

1.55

1.08

1.6

2.0

u/field

2.3

2.1

0.07

(40768800) Prostate Pathology biopsy report

351

0.68

1.08

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

338

1.34

1.08

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

107

895

1.20

1.07

1.6

iu/ml

0.4

0.2

0.23

167

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.65

1.06

1.8

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

371

3393

1.11

1.05

2.4

2.7

ug/g

126.4

131.9

0.13

303

2778

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

844

0.80

1.03

1.4

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

154

1.50

1.03

2.0

1.6

mg/l

4.3

3.8

0.20

149

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.84

1.02

2.0

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

114

1.58

1.02

1.1

1.0

ng/l

32.6

38.9

0.51

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.89

1.01

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

282

1.35

1.00

1.4

1.3

nmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

115

1.57

0.99

1.1

1.0

ng/l

216.8

251.2

0.54

(3002523) Influenza virus A Ag [Presence] in Specimen

606

0.77

0.99

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

606

0.77

0.99

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.84

0.98

1.6

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

160

0.56

0.98

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.97

0.0

1.0

—

(4094501)

626

0.78

0.96

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

108

1.58

0.96

1.3

2.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

108

1.58

0.96

1.3

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

108

1.58

0.96

1.3

2.3

—

(3022145) Colonoscopy Study observation

283

2569

1.11

0.94

1.3

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

833

0.81

0.94

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

411

1.27

0.90

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

172

1521

1.14

0.90

1.4

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

978

1.17

0.89

1.2

u/ml

0.3

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

202

1.39

0.89

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

369

0.73

0.87

1.2

1.4

pmol/l

60.1

155.4

0.60

113

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.86

0.87

2.6

1.7

mmol/l

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

162

1.42

0.84

1.6

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

129

1.48

0.83

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

177

0.62

0.81

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.61

0.81

1.0

1.5

—

(4306422)

463

1.24

0.81

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

626

5931

1.07

0.80

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.78

1.0

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

1.67

0.74

5.1

12.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

160

0.62

0.73

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

307

1.27

0.73

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.84

0.73

1.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

108

1.48

0.73

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

108

1.48

0.73

1.3

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

100

1.50

0.72

1.2

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

461

1.22

0.72

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.75

0.71

1.7

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

134

1.42

0.71

1.2

1.1

miu/ml

1597.1

1500.7

0.13

134

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.58

0.71

6.7

5.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

377

0.77

0.70

1.2

1.3

mmol/l

7.3

6.9

0.20

274

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.85

0.68

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.56

0.68

2.3

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.60

0.68

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

548

1.19

0.67

2.1

1.8

—

(44806420)

1.63

0.66

1.3

2.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.63

0.66

1.4

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

462

0.80

0.66

1.2

1.1

—

11.1

—

(4146454)

197

1.32

0.65

3.5

2.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

103

1.46

0.65

1.2

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

1.39

0.64

1.3

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

821

1.15

0.64

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

1.73

0.64

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2461

24881

0.94

0.63

4.3

3.9

mmol/l

4.5

4.8

39.19

2271

23655

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.61

1.2

3.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

420

3968

1.07

0.61

1.3

1.2

u/ml

9.1

10.1

0.13

118

1685

(1761482) Bacteria [#/volume] in Urine by Culture

416

1.21

0.61

6.2

3.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.1

—

(3024263) Appearance of Synovial fluid

105

1.43

0.60

1.1

1.9

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.58

0.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.51

0.58

1.3

1.2

—

(3008898) HLA-B27 [Presence]

100

1127

0.88

0.58

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.72

0.57

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.57

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.58

0.56

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

102

907

1.13

0.56

4.3

2.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.54

0.55

1.4

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

239

1.26

0.55

1.2

1.4

mmol/l

13.9

12.4

0.47

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.58

0.54

1.8

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.58

0.54

1.8

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

740

1.14

0.53

1.9

1.7

—

(3034426) Prothrombin time (PT)

108

1.39

0.53

1.0

1.3

—

(3022689) Creatine [Moles/volume] in Urine

1.45

0.53

1.7

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

158

0.70

0.52

1.5

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

508

1.16

0.51

2.4

2.6

ug/min

232.4

134.5

0.46

329

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

100

0.60

0.51

1.3

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

224

0.76

0.49

2.4

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

443

0.83

0.49

1.1

u/ml

4.3

2.1

0.38

238

(21494434) Karyotype in Bone marrow

163

1.29

0.48

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

166

0.72

0.47

1.1

—

(4024509)

154

0.71

0.47

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

111

1.35

0.46

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

718

7417

0.96

0.45

3.5

3.7

ug/l

2.4

2.0

0.27

617

6771

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

396

0.83

0.45

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2534

25131

1.05

0.45

4.7

4.2

mmol/l

2.7

2.9

25.85

2334

23745

(4133840)

0.59

0.45

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.40

0.45

1.7

1.2

34.3

28.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

265

1.21

0.44

1.1

1.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.37

0.44

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.37

0.44

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.37

0.44

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.37

0.44

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

238

1.22

0.44

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

230

0.78

0.43

1.2

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

128

0.70

0.43

1.6

2.3

ug/l

20.2

264.2

—

115

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.61

0.43

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

122

1.31

0.42

1.3

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

122

1119

1.09

0.42

2.0

u/l

46.6

39.7

1.72

111

1022

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.63

0.42

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

173

0.75

0.42

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

424

0.85

0.41

1.3

ug/l

3.0

3.2

0.14

393

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.43

0.41

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

1.52

0.41

2.2

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.41

0.0

2.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

5.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

710

1.12

0.40

1.9

2.1

mg/l

13.3

10.5

1.60

664

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.33

0.40

1.9

2.2

ug/l

98.5

56.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

397

3803

1.05

0.40

1.6

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

168

1.25

0.40

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

238

0.80

0.40

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

41.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

269

1.19

0.39

1.1

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

484

1.14

0.39

1.4

1.5

nmol/l

0.2

0.4

3.45

392

(3045414) Leukocytes [Presence] in Urine

969

0.91

0.39

1.6

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

193

0.78

0.39

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.36

0.38

1.1

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.39

0.38

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

192

0.78

0.38

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

1.35

0.38

7.8

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

462

0.86

0.38

4.1

3.2

mg/l

20.5

24.2

0.25

286

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.31

0.37

1.7

1.3

51.9

49.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.35

0.37

7.2

8.0

umol/l

0.2

0.3

—

(3014271) Vancomycin [Susceptibility]

1.27

0.36

2.9

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

631

1.11

0.35

1.8

2.0

iu/l

3.2

4.3

0.88

240

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.35

1.2

1.3

—

(3004451) EKG impression Narrative

108

1.30

0.35

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

264

1.18

0.34

1.1

1.6

—

(4027681)

209

1.20

0.34

1.2

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.33

0.33

2.0

2.8

—

177.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.33

0.33

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

191

1.21

0.33

3.2

2.6

—

(3006462) Nitrate [Presence] in Urine

0.67

0.33

2.2

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

303

1.16

0.33

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

266

1.17

0.32

1.1

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

155

1.23

0.32

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

1.35

0.32

1.2

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

252

0.83

0.32

1.1

1.6

mmol/l

7.2

7.6

0.35

151

(3024522) Salmonella sp identified in Specimen by Organism specific culture

267

1.16

0.31

1.1

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

267

1.16

0.31

1.1

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.35

0.31

2.0

1.2

9.0

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

138

1.23

0.30

4.2

7.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

268

1.16

0.30

1.1

1.3

g/l

6.7

0.03

187

(3024139) IgG subclass 3 [Mass/volume] in Serum

268

1.16

0.30

1.1

1.3

g/l

0.4

0.54

186

(3008536) Aspergillus sp Ab [Presence] in Serum

1.25

0.29

1.4

2.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

269

1.15

0.29

1.1

1.3

g/l

3.1

0.04

188

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

130

1.23

0.28

3.1

2.5

nmol/l

61.8

84.8

1.27

125

(1617658) Protocol used for examination of sentinel lymph nodes

151

0.79

0.28

1.0

1.1

—

(4062490)

270

1.15

0.28

1.1

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

122

1.23

0.27

1.3

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

812

0.92

0.27

1.6

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

141

1.21

0.26

1.0

1.2

—

(44813793)

188

1.17

0.25

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

264

0.87

0.23

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

457

1.10

0.23

1.7

2.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.25

0.22

1.0

1.3

mg/l

1.0

304.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

174

1816

0.96

0.22

1.2

iu/ml

113.2

155.2

0.54

699

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

172

1647

1.05

0.22

1.2

1.3

au/ml

30.2

51.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

4.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.7

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(4211845)

101

0.79

0.21

1.9

2.6

—

(4015189)

1.16

0.21

1.4

3.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.16

0.21

1.2

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.6

—

(3045424) Erythrocytes [Presence] in Urine

387

0.90

0.20

1.6

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.20

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3017704) Immunofixation for Urine

1.21

0.17

1.5

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

138

1.16

0.17

2.1

2.6

umol/l

45.3

51.6

0.35

119

(40768795) Lymph node Pathology biopsy report

205

1.12

0.17

1.8

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

111

1.17

0.15

1.6

1.7

—

8.5

—

(3017732) Neutrophils [#/volume] in Blood

174

1684

1.04

0.15

2.8

2.6

e9/l

4.1

0.09

133

1396

(3032773) Endomysium IgG Ab [Titer] in Serum

234

0.90

0.15

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

676

6667

1.02

0.15

3.6

2.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.81

0.14

1.1

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.81

0.14

1.1

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

247

1.09

0.13

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.16

0.11

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

222

1.08

0.10

4.1

2.9

nmol/l

2.0

29.8

0.59

217

(3047007) Chlamydophila sp Ab [Presence] in Serum

422

0.95

0.09

1.3

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

763

1.04

0.09

1.1

u/ml

1.4

3.6

1.08

114

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

149

1457

1.02

0.08

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

101

982

1.03

0.08

2.5

2.8

u/ml

52.4

42.9

0.23

951

(40768793) Breast Pathology biopsy report

419

0.95

0.08

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.12

0.07

1.5

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

186

1.08

0.07

6.4

3.8

mu/l

24.0

33.4

0.74

179

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

412

1.04

0.07

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.84

0.07

1.6

1.2

—

(3022621) pH of Urine by Test strip

139

1363

1.02

0.07

2.5

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.84

0.06

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

101

0.89

0.06

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

171

0.94

0.05

1.1

ratio

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

943

1.02

0.04

1.9

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.09

0.03

3.4

3.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

249

2473

1.01

0.03

4.0

3.9

30.4

0.01

180

1808

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

262

1.03

0.02

1.2

mg/l

48.9

41.4

0.24

214

(3005322) IgE [Units/volume] in Serum or Plasma

175

1741

1.01

0.01

1.2

1.3

u/ml

270.0

242.4

0.09

162

1623

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

753

1.01

0.01

1.2

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

165

0.97

0.00

1.2

—

73.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

251

1.00

0.00

1.1

mg/l

208.0

269.9

2.47

216

(3038177) Helicobacter pylori Ab [Presence] in Serum

485

1.01

0.00

1.5

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

178

1785

1.00

0.00

2.2

2.4

au/ml

34.4

21.4

—

138

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

166

1.02

0.00

1.8

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

202

0.99

0.00

1.2

u/ml

0.0

0.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

163

0.98

0.00

1.2

—

43.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

187

1.02

0.00

1.1

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.89

0.00

3.2

2.6

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.0

—

880.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.94

0.00

1.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.2

—

118.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.98

0.00

1.6

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

150.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.91

0.00

4.3

3.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.9

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.6

—

13.8

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_VIRAL_HEPATITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_VIRAL_HEPATITIS	4.452 [3.77, 5.25]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 890 out of 8567 females with AB1_VIRAL_HEPATITIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_VIRAL_HEPATITIS	5.976 [5.33, 6.7]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 2626 out of 13772 males with AB1_VIRAL_HEPATITIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_VIRAL_HEPATITIS.

N-year risk	Females	Males
1	0.319%	0.893%
5	2.193%	6.033%
10	5.343%	15.19%
15	10.523%	28.411%
20	17.402%	43.684%

Relationships between endpoints

↥

Index endpoint: AB1_VIRAL_HEPATITIS – Viral hepatitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Viral hepatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints